MarketPeel
Insider Trading Intelligence
Pricing
…
JP

Jan Pinkas

CBIO
CHIEF SCIENTIFIC OFFICER · CRESCENT BIOPHARMA, INC. · CIK 0002077126
FILING MIX · LIFETIME80%/20%
BUYS
4
SELLS
1
TOTAL VALUE
$23.2K
COMPANIES
1
ACTIVE SINCE
Jul 2025
HOLDINGS NOW
22,239
AVG SELL PX
$17.99
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Jan Pinkas. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
CBIO · 22,239 shares · as of Jun 22, 2026
035,61971,237106,856142,4742026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2025
2025
2026
2026
FLOW · 4 buys / 1 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CBIO
CRESCENT BIOPHARMA, INC.
SALE10b5-1
10b5-1 plan
1,288$17.99$23.2K22,239Jun 22, 2026Jun 23, 2026 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
70,025——70,025Dec 15, 2025Dec 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
17,507——17,507Dec 15, 2025Dec 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
5,000——22,507Dec 15, 2025Dec 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
142,474——142,474Jul 16, 2025Jul 16, 2025 ↗View →
Other insiders · CBIO
Loading peer insiders…
About this filer
CIK 0002077126
ROLE
Chief Scientific Officer
PRIMARY
CBIO
COMPANIES
1
ACTIVE SINCE
Jul 2025
MARKETPEEL · /INSIDER/0002077126DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback